Should terminally ill patients have the right to take drugs that pass phase I testing? Yes.
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 17823187.
- Also identified by PMC identifier 1971171.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The United States is considering allowing experimental drugs to be given to people at the end of life. <b>Emil J Freireich </b>believes patients should be able to judge the risks for themselves, and <b>Dean Gesme</b> counters that use of such drugs outside trials will damage both individuals and science
Medical subject headings
- Antineoplastic Agents
- Neoplasms
- Terminally Ill